메뉴 건너뛰기




Volumn 25, Issue 4, 2010, Pages 226-228

Selective depletion of peripheral granulocyte/monocyte enhances the efficacy of scheduled maintenance infliximab in crohn's disease

Author keywords

Crohn's disease; Inflammatory bowel disease; Infliximab; Maintenance therapy; Selective granulocyte and monocyte adsorption

Indexed keywords

INFLIXIMAB; MESALAZINE;

EID: 77956275043     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20242     Document Type: Article
Times cited : (20)

References (11)
  • 4
    • 0018292706 scopus 로고
    • National cooperative Crohn's disease study: Study design and conduct of the study
    • Winship DH, Summers RW, Singleton JW, Best WR, Becktel JM, Lenk LF, Kern F Jr. National cooperative Crohn s disease study: study design and conduct of the study. Gastroenterology 1979;77:829-842. (Pubitemid 9257851)
    • (1979) Gastroenterology , vol.77 , Issue.4 II , pp. 829-842
    • Winship, D.H.1    Summers, R.W.2    Singleton, J.W.3
  • 5
    • 0029775580 scopus 로고    scopus 로고
    • The Short Inflammatory Bowel Disease Questionnaire: A quality of life instrument for community physicians managing inflammatory bowel disease
    • CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial
    • Irvine EJ, Zhou Q, Thompson AK. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial. Am J Gastroenterol 1996;91:1571-1578.
    • (1996) Am J Gastroenterol , vol.91 , pp. 1571-1578
    • Irvine, E.J.1    Zhou, Q.2    Thompson, A.K.3
  • 6
    • 0037379792 scopus 로고    scopus 로고
    • Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: A randomized controlled trial
    • DOI 10.1053/gast.2003.50145
    • Farrel RJ, Alsahli M, Jeen YT, Falchuk KR, Peppercorn MA, Michetti P. Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn s disease: a randomized controlled trial. Gastroenterology 2003;124:917-924. (Pubitemid 36389794)
    • (2003) Gastroenterology , vol.124 , Issue.4 , pp. 917-924
    • Farrell, R.J.1    Alsahli, M.2    Jeen, Y.-T.3    Falchuk, K.R.4    Peppercorn, M.A.5    Michetti, P.6
  • 7
    • 78751483298 scopus 로고    scopus 로고
    • FDA news release, 4 August available at: Accessed October 22nd, 2009
    • Cancer Warnings Required for TNF Blockers. FDA news release, The U.S. Food and Drug Administration, 4 August 2009, available at: http://www.fda.gov/ NewsEvents/Newsroom/PressAnnouncements/ucm175803.htm Accessed October 22nd, 2009.
    • (2009) Cancer Warnings Required for TNF Blockers
  • 9
    • 0031903013 scopus 로고    scopus 로고
    • Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation
    • Nikolaus S, Bauditz J, Gionchetti P. Increased secretion of proinflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin-10 during intestinal inflammation. Gut 1998;42:470-476. (Pubitemid 28186561)
    • (1998) Gut , vol.42 , Issue.4 , pp. 470-476
    • Nikolaus, S.1    Bauditz, J.2    Gionchetti, P.3    Witt, C.4    Lochs, H.5    Schreiber, S.6
  • 10
    • 0031835846 scopus 로고    scopus 로고
    • A role for granulocyte and monocyte apheresis in the treatment of rheumatoid arthritis
    • Kashiwagi N, Hirata I, Kasukawa R. A role for granulocyte and monocyte apheresis in the treatment of rheumatoid arthritis. Ther Apher 1998;2:134-141. (Pubitemid 28311172)
    • (1998) Therapeutic Apheresis , vol.2 , Issue.2 , pp. 134-141
    • Kashiwagi, N.1    Hirata, I.2    Kasukawa, R.3
  • 11
    • 67649643627 scopus 로고    scopus 로고
    • Treating ulcerative colitis by Adacolumn therapeutic leucocytapheresis: Clinical efficacy and safety based on surveillance of 656 patients in 53 centres in Japan
    • Hibi T, Sameshima Y, Sekiguchi Y, Hisatome Y, Maruyama F, Moriwaki K, Shima C, Saniabadi AR, Matsumoto T. Treating ulcerative colitis by Adacolumn therapeutic leucocytapheresis: clinical efficacy and safety based on surveillance of 656 patients in 53 centres in Japan. Dig Liver Dis 2009;41:570-577.
    • (2009) Dig Liver Dis , vol.41 , pp. 570-577
    • Hibi, T.1    Sameshima, Y.2    Sekiguchi, Y.3    Hisatome, Y.4    Maruyama, F.5    Moriwaki, K.6    Shima, C.7    Saniabadi, A.R.8    Matsumoto, T.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.